case_images: PMC7695685_01
case_images: PET CT scan of the chest-mediastinal window. Neoplastic aorto-pulmonary, mediastinal para aortic and left paravertebral lymph nodes. (A) Baseline disease. (B) Complete disease response after 12 weeks of therapy with osimertinib.
case_images: OTT-13-12027-g0001.jpg
case_images: PMC7695685_01_OTT-13-12027-g0001.jpg
case_images: f0001
case_images: During follow-up, a Computed Tomography (CT) scan performed in November 2019 and a Positron Emission Tomography CT (PET-CT) scan in December 2019 showed disease recurrence in multiple small lung nodes and mediastinal para aortic, aorto-pulmonary and left paravertebral lymph nodes (Figures 1A and 2A). On the 21st of April 2020, a restaging PET CT scan demonstrated a disease complete response to osimertinib (Figures 1B and 2B).
case_images: Chest CT scan. (A) Baseline disease in multiple small lung nodes. (B) Complete disease response after 12 weeks of therapy with osimertinib.
case_images: OTT-13-12027-g0002.jpg
case_images: PMC7695685_01_OTT-13-12027-g0002.jpg
case_images: f0002
case_images: During follow-up, a Computed Tomography (CT) scan performed in November 2019 and a Positron Emission Tomography CT (PET-CT) scan in December 2019 showed disease recurrence in multiple small lung nodes and mediastinal para aortic, aorto-pulmonary and left paravertebral lymph nodes (Figures 1A and 2A). On the 21st of April 2020, a restaging PET CT scan demonstrated a disease complete response to osimertinib (Figures 1B and 2B).